Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF.

Saved in:
Bibliographic Details
Title: Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF.
Authors: Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Henderson AD; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lay-Flurrie J; Bayer PLC, Research & Development, Pharmaceuticals, Reading, United Kingdom., Viswanathan P; Bayer, Research & Development, Pharmaceuticals, Whippany, New Jersey, USA., Lage A; Bayer, Research & Development, Pharmaceuticals, Sao Paolo, Brazil., Scheerer MF; Bayer AG, Global Medical Affairs, Berlin, Germany., Lam CSP; National Heart Centre Singapore & Duke-National University of Singapore, Singapore., Senni M; University Bicocca Milan, Milan, Italy; Papa Giovanni XXIII Hospital, Bergamo, Italy., Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Voors AA; University Medical Center Groningen, Groningen, the Netherlands., Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany., Fonseca C; Department of Internal Medicine, Hospital São Francisco Xavier, NOVA MEDICAL School, Universidade Nova de Lisboa, Lisbon, Portugal., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri, USA., Linssen GCM; Department of Cardiology, Hospital Group Twente, Almelo, the Netherlands., Petrie MC; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark., Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Zannad F; Université de Lorraine, INSERM Clinical Investigation Centre, CHU, Nancy, France., Pitt B; University of Michigan, School of Medicine, Ann Arbor, Michigan, USA., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
Source: Journal of the American College of Cardiology [J Am Coll Cardiol] 2025 Jan 21; Vol. 85 (2), pp. 140-155. Date of Electronic Publication: 2024 Dec 10.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-3597
DOI:10.1016/j.jacc.2024.10.111